ATYR
ATYR
NASDAQ · Biotechnology

Atyr Pharma Inc

Penny Stocks Biotech Stocks Healthcare Stocks
$0.53
+0.14 (+34.12%)
As of May 16, 2:14 AM ET ·
Analyst Consensus
Hold
16
Analysts
High
Coverage
Buy 8 50%
Hold 8 50%
Sell 0 0%
Price Target
Analyst Price Target +2,126.0% upside
Low Target $9.31
Average Target $11.82
High Target $19.97
Current Price $0.53
Current
$0.53
Target
$11.82
$9.31 $11.82 avg $19.97
Scenario Analysis
Bear Case
$9.31
1,653.3%
Low target
Base Case
$11.82
+2,126.0%
Avg target
Bull Case
$19.97
+3,660.8%
High target
Risk/Reward
2.2x
Favorable
Price in Context
52-Week High
$7.29
-92.7% from high
52-Week Low
$0.40
+34.4% from low
Target vs 52W High
$11.82
+62.1% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 40 75% $257.58 +22.4%
AMGN
Amgen Inc
 Hold 44 48% $190.87 -41.5%
GILD
Gilead Sciences Inc
 Strong Buy 39 79% $362.68 +179.9%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 79% $438.34 +0.3%
REGN
Regeneron Pharmaceuticals
 Strong Buy 38 79% $76.80 -89.0%
ALNY
Alnylam Pharmaceuticals Inc
 Strong Buy 36 75% $102.31 -64.3%
RVMD
Revolution Medicines Inc
 Strong Buy 27 96% $114.11 -21.7%
BIIB
Biogen Inc
 Buy 43 56% $91.45 -52.6%